Drug regulator wants to cull animal testing

In a Draize test, a researcher applies testing drugs on animals

Image
Deepak Patel New Delhi
Last Updated : Jun 02 2016 | 1:26 AM IST
Can a controversial toxicity test of drugs on the eyes or skin of animals be replaced, the Drug Controller General of India (DCGI) asked pharmaceutical companies and laboratories on Wednesday.

In a Draize test, a researcher applies testing drugs on animals.

To deal with this sensitive issue, the regulator had formed a committee that met on May 23 for the first time. The committee said as there was an international movement to replace tests on animals with alternatives, it should be considered here also. A decision would be taken only after obtaining assessment of feasibility, validation and preparedness of Indian laboratories.

The procedure generally involves applying 0.5 millilitre or 0.5g of a test substance to the eye or skin of a restrained, conscious animal. After a stipulated period, the effects of the drug are recorded.

The animals (generally rabbits) are observed for up to 14 days for signs of erythema or edema in skin tests, and redness, swelling, discharge, ulceration, haemorrhaging, cloudiness, or blindness in eye tests. If the test renders irreversible damage to the eye or skin, the animals are euthanised.

One of the main contentions of the committee was if pre-clinical testing labs in India were equipped for such a change. "Have the alternative methods been validated, particularly in India? Do we have adequate number of laboratories to undertake toxicity testing of all required substances by alternative methods?" the committee asked.

The drug regulator has given two weeks to laboratories carrying out such tests - from the public sector, private sector and related organisation from the pharmaceutical industry - to send their responses.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 02 2016 | 12:25 AM IST

Next Story